Clinical trial
INVEST: INternational VErapamil SR Trandolapril STudy
NCT00133692 · University of Florida, Other · Completed
Key facts
| NCT number | NCT00133692 |
|---|---|
| Title | INVEST: INternational VErapamil SR Trandolapril STudy |
| Official title | INternational VErapamil SR Trandolapril STudy |
| Lead sponsor | University of Florida, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Verapamil SR/Trandolapril/Hydrochlorothiazide (HCTZ), Atenolol/HCTZ/Trandolapril |
| Enrollment | 22,000 |
| Start date | Sep 1, 1997 |
| Completion | Feb 1, 2003 |
| First posted | Aug 23, 2005 |
| Last update posted | Sep 20, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: